NSE filing, NSE: CENTURYPLY. Summary written from the filing by ALFA Finder's alert engine.
Century Plyboards (India) Ltd: key numbers
- Share price
- ₹642.50
- Market cap
- ₹14,275 Cr
- Revenue (annual)
- ₹5,397 Cr
- Net profit (annual)
- ₹262.7 Cr
- P/E (TTM)
- 49.0×Sector 41.9×
- Promoter holding
- 71.83%+0.00% QoQ
- FII holding
- 3.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Century Plyboards (India) Ltd
All →Century Plyboards (India) Other Announcement
Century Plyboards (India) Ltd submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Century Plyboards (India) Management Change
Century Plyboards re-appointed five directors at its 16 Sep 2026 AGM, including Sanjay Agarwal as CEO & MD for five years. No monetary transaction is involved.
Century Plyboards (India) Annual General Meeting
Century Plyboards filed proceedings of its 45th AGM held on September 16, 2026. All resolutions including director re-appointments, CEO re-appointment, and borrowing limit increase were passed.
Century Plyboards (India) Dividend
Century Plyboards' 45th AGM is scheduled for September 16, 2026. The company also declared a final dividend of Re. 1 per equity share.
Century Plyboards (India) Business Update
Century Plyboards filed its Business Responsibility and Sustainability Report for FY 2025-26, fulfilling regulatory compliance requirements under SEBI (LODR) regulations.
Century Plyboards (India) Annual General Meeting
Century Plyboards has issued the notice for its 45th Annual General Meeting to be held on September 16, 2026. The agenda includes dividend declaration and re-appointments.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.